Phase 2 randomized controlled trial of intravenous or intraperitoneal paclitaxel plus mFOLFOX6 vs. mFOLFOX6 as first-line treatment of advanced gastric cancer - Shen Zhao; Liyu Su; Yigui Chen; Xiaofeng Li; Peicheng Lin; Wujin Chen; Wenzheng Fang; Jinfeng Zhu; Hui Li; Liping Ren; Jie Liu; Yanni Hong; et al. (Frontiers in Oncology, 2022)